Iambic Therapeutics Inc. carries a market capitalization of 223.22M, placing it among publicly traded companies globally.
| Market Cap | 223.22M |
| Enterprise Value | N/A |
Iambic Therapeutics Inc.'s stock has gained approximately 40.22379% over the past 52 weeks. The 50-day moving average sits at 21.36, while the 200-day moving average is 21.36.
| Beta (5Y) | N/A |
| 52-Week Price Change | 40.22379% |
| 50-Day Moving Average | 21.36 |
| 200-Day Moving Average | 21.36 |
| Average Volume (20 Days) | N/A |